Mechanism of cell death in acute-on-chronic liver failure: A clinico-pathologic-biomarker study

Liver International

Volumn 35, Issue 12, 2015, Pages 2564-2574

  Adebayo, Danielle ^a   Morabito, Vincenzo ^a   Andreola, Fausto ^a   Pieri, Giulia ^a   Luong, Tu Vin ^a   Dhillon, Amar ^a   Mookerjee, Rajeshwar ^a   Jalan, Rajiv ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cell death; Liver failure; Necrosis

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CYTOKERATIN; GENOMIC DNA; CYTOKERATIN 18; M30 CYTOKERATIN-18 PEPTIDE, HUMAN; PEPTIDE FRAGMENT;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIVER BIOPSY; LIVER CELL; MALE; MORTALITY; APOPTOSIS; BLOOD; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; APOPTOSIS; BIOMARKERS; CASPASE 3; CELL DEATH; FEMALE; HUMANS; KERATIN-18; LIVER; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; STATISTICS AS TOPIC;

EID: 84983097979     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12850     Document Type: Article

References (31)

1. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-37, 37 e1-9.
2. Olson JC, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology 2011; 54: 1864-72.
3. Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology 2014; 147: 4-10.
4. Roth GA, Lubsczyk BA, Pilz J, et al. Nucleosome serum levels in acute hepatic failure and MARS treatment. Transpl Proc 2009; 41: 4207-10.
5. Zou Y, Chen T, Han M, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol 2010; 184: 466-75.
6. Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Investig 2009; 119: 1794-805.
7. Yilmaz Y, Dolar E, Ulukaya E, et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007; 13: 837-44.
8. Yilmaz Y, Dolar E, Ulukaya E, et al. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Med Sci Monit 2009; 15: CR189-93.
9. Papatheodoridis GV, Hadziyannis E, Tsochatzis E, et al. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. J Clin Gastroenterol 2010; 44: e87-95.
10. Zheng SJ, Liu S, Liu M, et al. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2014; 20: 2403-11.
11. Kramer G, Erdal H, Mertens HJ, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 2004; 64: 1751-6.
12. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143: 1158-72.
13. Li X, Wang LK, Wang LW, et al. Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. Inflamm Res 2013; 62: 703-9.
14. Zhou RR, Liu HB, Peng JP, et al. High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury. Exp Mol Pathol 2012; 93: 213-9.
15. Bechmann LP, Jochum C, Kocabayoglu P, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010; 53: 639-47.
16. Moreau R, Arroyo V. Acute-on-chronic liver failure: a new clinical entity. Clin Gastroenterol Hepatol 2015; 13: 836-41.
17. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-37.
18. Mookerjee RP, Lackner C, Stauber R, et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol 2011; 55: 1103-11.
19. Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50: 1072-8.
20. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437-43.
21. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009; 361: 1570-83.
22. Lemasters JJ. Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology 2005; 129: 351-60.
23. Antoine DJ, Jenkins RE, Dear JW, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012; 56: 1070-9.
24. El-Hassan H, Anwar K, Macanas-Pirard P, et al. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases. Toxicol Appl Pharmacol 2003; 191: 118-29.
25. Pierce RH, Franklin CC, Campbell JS, et al. Cell culture model for acetaminophen-induced hepatocyte death in vivo. Biochem Pharmacol 2002; 64: 413-24.
26. Li H, Xia Q, Zeng B, et al. Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol 2015; 63: 50-9.
27. Schlatter R, Schmich K, Lutz A, et al. Modeling the TNFalpha-induced apoptosis pathway in hepatocytes. PLoS One 2011; 6: e18646.
28. Jiang N, Reich CF 3rd, Monestier M, Pisetsky DS. The expression of plasma nucleosomes in mice undergoing in vivo apoptosis. Clin Immunol 2003; 106: 139-47.
29. Jiang N, Pisetsky DS. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 2005; 77: 296-302.
30. Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 2002; 50: 449-54.
31. Tazi KA, Bieche I, Paradis V, et al. In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol 2007; 46: 1075-88.